Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05701917 · ClinicalTrials.gov registry record · NA
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
A NA study of Venous Thromboembolism and Deep Venous Thrombosis, sponsored by Inari Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 20
- Study locations
NCT05701917 is a NA study of Venous Thromboembolism and Deep Venous Thrombosis that is actively recruiting participants, run by Inari Medical. The registered enrollment target is 300 participants, below the 6,290-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (95% lower). The trial reports 20 study locations across 11 states.
The verdict
NCT05701917, a NA study of Venous Thromboembolism and Deep Venous Thrombosis, is actively recruiting participants, sponsored by Inari Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Management Arm) in the treatment of subjects with symptomatic unilateral iliofemoral DVT. The study will collect data on demographics, comorbidities, details from the DVT diagnosis and treatment, and clinical outcomes through the 6-month follow up visit.
Conditions Studied
Interventions
- DEVICE ClotTriever System
- DRUG Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc.
Study Locations (20)
Florida
- Manatee Memorial Hospital - Bradenton
- Baptist Health Research Institute - Jacksonville
- Lakeland Vascular Institute - Lakeland
- HCA Florida Largo Hospital - Largo
- Sarasota Memorial Hospital - Sarasota
- BayCare Health System - Tampa
Michigan
- McLaren Healthcare - Bay City
- Henry Ford Health - Detroit
- MyMichigan Medical Center - Midland
Arizona
- Honor Health - Scottsdale
- Pima Heart and Vascular - Tucson
California
- UCI Medical Center - Orange
- Vascular and Interventional Specialists of Orange County - Orange
Colorado
- University Of Colorado - Denver
Connecticut
- Yale University - New Haven
District of Columbia
- MedStar Health Research Institution - Washington D.C.
Georgia
- Memorial Health University Medical Center - Savannah
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-01-06 |
| Est. Completion | 2027-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05701917
The ClinicalTrials.gov registry entry for NCT05701917 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,290-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (95% lower). The listed sponsor is Inari Medical, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Venous Thromboembolism appearing as the primary indexed condition, and to 2 interventions - of which ClotTriever System is the first listed.
NCT05701917 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Florida, Michigan, Arizona.
Frequently Asked Questions
What is clinical trial NCT05701917 about?
NCT05701917 is a clinical study titled "DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis". This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Mana...
What is the current status of trial NCT05701917?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2023-01-06. Estimated completion is 2027-01-15.
What conditions does trial NCT05701917 study?
This clinical trial studies the following conditions: Venous Thromboembolism, Deep Venous Thrombosis, Post-Thrombotic Syndrome.
What interventions are being tested in trial NCT05701917?
The interventions under investigation include: ClotTriever System (DEVICE), Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc. (DRUG).
Who is sponsoring clinical trial NCT05701917?
This trial is sponsored by Inari Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05701917 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Connecticut, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Thromboembolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Glioblastoma Remote Monitoring and Care - Research Protocol
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
RECRUITING · NA
-
Warfarin Patient Self-management Implementation in the US Healthcare System
RECRUITING · NA
-
CLEANer Aspiration for Pulmonary Embolism
RECRUITING · NA
-
Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.